Literature DB >> 10406957

Terminal truncations in amp C beta-lactamase from a clinical isolate of Pseudomonas aeruginosa.

J Walther-Rasmussen1, A H Johnsen, N Høiby.   

Abstract

AmpC beta-lactamases from strains of Pseudomonas aeruginosa have previously been shown to be heterogeneous with respect to their isoelectric point (pI). In order to elucidate the origin of this heterogeneity enzymes were isolated from a clinical isolate of a multiresistant P. aeruginosa strain and biochemically characterized. The purification was accomplished in four chromatographic steps comprising dye-affinity, size-exclusion, hydrophobic interaction chromatography, and chromatofocusing; this resulted in five forms with pI values of 9.1, 8.7, 8.3, 8.2, and 7.6. When analysed by SDS/PAGE and agarose IEF each separated beta-lactamase appeared to be both size- and charge-homogeneous. The specific activities of the variants were very similar. MS of each isolated beta-lactamase form showed minor differences in molecular mass (range 40.0-40.8 kDa). MS of the beta-lactamase with a pI of 8.2 demonstrated the presence of two subforms. The N-terminal sequences of three of the beta-lactamases were identical to the published sequence [Lodge, J.M. , Minchin, S.D., Piddock, L.J.V. & Busby, J.W. (1990) Biochem. J. 272, 627-631], while two variants were truncated by two amino-acid residues, one of which was acidic. The previously published sequence contains an alanine as the ultimate residue, but two of the beta-lactamases showed a substitution of Ala371 for arginine, whereas in the remaining forms C-terminal truncations by one and three residues were found. Our results indicate that the P. aeruginosa strain does not harbour multiple copies of the ampC gene, but rather that the five beta-lactamase isoforms are products of a single structural gene. The combinations of the identified N- and/or C-terminal truncations explained the multiple pI values of the beta-lactamase isoforms.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10406957     DOI: 10.1046/j.1432-1327.1999.00529.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  6 in total

1.  Oxacillinase-mediated resistance to cefepime and susceptibility to ceftazidime in Pseudomonas aeruginosa.

Authors:  D Aubert; L Poirel; J Chevalier; S Leotard; J M Pages; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

2.  OXA-28, an extended-spectrum variant of OXA-10 beta-lactamase from Pseudomonas aeruginosa and its plasmid- and integron-located gene.

Authors:  L Poirel; D Girlich; T Naas; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

3.  Characterization of VIM-2, a carbapenem-hydrolyzing metallo-beta-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France.

Authors:  L Poirel; T Naas; D Nicolas; L Collet; S Bellais; J D Cavallo; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

4.  Biochemical Characterization of SFC-1, a class A carbapenem-hydrolyzing beta-lactamase.

Authors:  Fátima Fonseca; Ana Cristina Sarmento; Isabel Henriques; Bart Samyn; Jozef van Beeumen; Pedro Domingues; Maria Rosário Domingues; Maria José Saavedra; António Correia
Journal:  Antimicrob Agents Chemother       Date:  2007-09-17       Impact factor: 5.191

Review 5.  Beta-lactam antibiotics: from antibiosis to resistance and bacteriology.

Authors:  Kok-Fai Kong; Lisa Schneper; Kalai Mathee
Journal:  APMIS       Date:  2010-01       Impact factor: 3.205

6.  Prospective survey of beta-lactamases produced by ceftazidime- resistant Pseudomonas aeruginosa isolated in a French hospital in 2000.

Authors:  Christophe De Champs; Laurent Poirel; Richard Bonnet; Danielle Sirot; Catherine Chanal; Jacques Sirot; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2002-09       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.